Clinical efficacy of tezepelumab in pre-selected non-type 2 asthma patients.

Autor: Chin-See-Chong TCT; Department of Pulmonary Diseases, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., Valk JPMJV; Department of Pulmonary Diseases, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.; Department of Pulmonary Diseases, Erasmus Medical Centrum, Rotterdam, The Netherlands., Layhadi JAJ; National Heart and Lung Institute, Imperial College London, London, UK.; Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK., Shamji MHM; National Heart and Lung Institute, Imperial College London, London, UK.; Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK., Kappen JHJ; Department of Pulmonary Diseases, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.; National Heart and Lung Institute, Imperial College London, London, UK.; Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK.

Publikováno v: Allergy [Allergy] 2024 Oct; Vol. 79 (10), pp. 2867-2870. Date of Electronic Publication: 2024 Jul 22.